Literature DB >> 26542253

Inflammation is key to hemophilic arthropathy.

Alok Srivastava1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26542253     DOI： 10.1182/blood-2015-09-665091

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  6 in total

Review 1.  Pathological mechanism of joint destruction in haemophilic arthropathy.

Authors:  Haijia Zhu; Yilin Meng; Peijian Tong; Shanxing Zhang
Journal:  Mol Biol Rep       Date:  2020-12-08       Impact factor: 2.316

2.  The Application of Focused Medium-Energy Extracorporeal Shockwave Therapy in Hemophilic A Arthropathy.

Authors:  Wan-Shan Lo; Jiunn-Ming Sheen; Yu-Chieh Chen; Kuan-Ting Wu; Lin-Yi Wang; Yiu-Chung Lau; Chih-Cheng Hsiao; Jih-Yang Ko
Journal:  Healthcare (Basel)       Date:  2022-02-11

3.  EPCR deficiency or function-blocking antibody protects against joint bleeding-induced pathology in hemophilia mice.

Authors:  Jhansi Magisetty; Usha R Pendurthi; Charles T Esmon; L Vijaya Mohan Rao
Journal:  Blood       Date:  2020-06-18       Impact factor: 22.113

4.  Initial joint bleed volume in a delayed on-demand treatment setup correlates with subsequent synovial changes in hemophilic mice.

Authors:  Kåre Kryger Vøls; Mads Kjelgaard-Hansen; Carsten Dan Ley; Axel Kornerup Hansen; Maj Petersen
Journal:  Animal Model Exp Med       Date:  2020-06-03

5.  Comparative Analysis of the Occurrence and Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Hemophilic Arthropathy and Osteoarthritis.

Authors:  Piotr Wojdasiewicz; Łukasz A Poniatowski; Andrzej Kotela; Marta Skoda; Michał Pyzlak; Aleksandra Stangret; Ireneusz Kotela; Dariusz Szukiewicz
Journal:  J Immunol Res       Date:  2020-08-20       Impact factor: 4.818

6.  Plasma levels of IL-1β and IL-37 in patients with severe haemophilia.

Authors:  Pei-Chin Lin; Shyh-Shin Chiou; Wan-Yi Hsu; Yu-Mei Liao; Shih-Pien Tsai; Hsiu-Lan Su; Ping-Tao Lu; Yu-Hsin Tseng
Journal:  J Int Med Res       Date:  2020-07       Impact factor: 1.671
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.